NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Recruiting now
Conditions studied: Intracranial Aneurysm
In brief
The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.
Key facts
- Study ID
- NCT06604884
- Run by
- Medtronic Neurovascular Clinical Affairs
- People needed
- 118
- Starts
- 2025-12-12
- Expected to finish
- 2033-09-01
- Last updated by the study team
- 2026-06-23
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient or legally authorized representative (LAR) has provided written informed consent using the Ethics Board and Medtronic approved Informed Consent Form and agrees to comply with the protocol requirements. HIPAA/data protection authorization has been provided and signed by the patient (or patient's LAR) as applicable per local law.
- Patient has an intracranial aneurysm intended to be treated with the Pipeline™ Vantage Embolization Device with Shield Technology™.
- Patient is an adult per local law at time of consent.
You may not qualify if…
- Patient with any contraindications for the device or procedure per the Pipeline™ Vantage Device local geography IFU.
- Patient who may be unable to complete the study follow-up.
- The Investigator determined that the health of the patient may be compromised by the patient's enrollment.
- Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
- Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results.
Where it is running
- Baptist Medical Center Jacksonville — Jacksonville, Florida, United States (enrolling)
- Wellstar Research Institute — Marietta, Georgia, United States (enrolling)
- Ascension St. Vincent Hospital Indianapolis Goodman Campbell Brain and Spine — Carmel, Indiana, United States (enrolling)
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States (enrolling)
- McLaren Healthcare — Flint, Michigan, United States (enrolling)
- Prisma Health — Greenville, South Carolina, United States (enrolling)
- Semmes Murphey Clinic/Semmes Murphy Foundation — Memphis, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.